Suchergebnisse - "Kawazoe, Hitoshi"

PubPharm (65)

1

Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer

enthalten in: The oncologist | 2024

von Takahashi, K. | Uozumi, R. | Mukohara, T. | +17

2

Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended-Spectrum β-lactamase producing Enterobacterales (ESBL-E)

enthalten in: Pharmacotherapy | 2024

von Namiki, T. | Yokoyama, Y. | Hashi, H. | +6

3

Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrumβ‐lactamase producing Enterobacterales ( ESBL‐E)

enthalten in: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | 2024

von Namiki, T. | Yokoyama, Y. | Hashi, H. | +6

4

Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer : A retrospective observational study

enthalten in: Cancer medicine | 2023

von Yokokawa, T. | Suzuki, K. | Tsuji, D. | +17

5

Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy : a multicenter retrospective study

enthalten in: Scientific reports | 2023

von Tashiro, R. | Kawazoe, H. | Mamishin, K. | +12

6

Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that of clinically used anticancer agents

enthalten in: Journal of natural medicines | 2023

von Kikuyama, F. | Suzuki, S. | Jibiki, A. | +4

7

Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer : a Prospective Observational Study

enthalten in: Investigational new drugs | 2023

von Ishikawa, E. | Yokoyama, Y. | Chishima, H. | +18

8

Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet : A Multicenter Retrospective Study

enthalten in: Journal of Cancer | 2023

von Nasu, I. | Kondo, M. | Uozumi, R. | +19

9

Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that of clinically used anticancer agents

enthalten in: Journal of natural medicines | 2023

von Kikuyama, F. | Suzuki, S. | Jibiki, A. | +4

10

Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that of clinically used anticancer agents

enthalten in: Journal of natural medicines | 2023

von Kikuyama, F. | Suzuki, S. | Jibiki, A. | +4

1
2
3
4
5
6
7
Nächster »
[7]